Latest Insider Transactions at Lemonade, Inc. (LMND)
This section provides a real-time view of insider transactions for Lemonade, Inc. (LMND). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lemonade, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lemonade, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2023
|
Adina Eckstein Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,500
+15.46%
|
-
|
|
Jul 17
2023
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.47%
|
$100,000
$20.0 P/Share
|
|
Jul 17
2023
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.65%
|
$25,000
$5.26 P/Share
|
|
Jun 07
2023
|
Silvija Martincevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+29.7%
|
-
|
|
Jun 07
2023
|
Irina Novoselsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+29.7%
|
-
|
|
Jun 07
2023
|
Mwashuma Kamata Nyatta Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,800
+35.85%
|
-
|
|
Jun 05
2023
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
538
-1.11%
|
$9,684
$18.26 P/Share
|
|
Jun 05
2023
|
Timothy E Bixby Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,474
-0.55%
|
$26,532
$18.26 P/Share
|
|
Mar 31
2023
|
Alex Clavel |
SELL
Other acquisition or disposition
|
Indirect |
11,983,384
-100.0%
|
-
|
|
Mar 07
2023
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
663
-1.35%
|
$9,282
$14.94 P/Share
|
|
Mar 07
2023
|
Timothy E Bixby Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,945
-0.72%
|
$27,230
$14.94 P/Share
|
|
Feb 07
2023
|
Timothy E Bixby Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,000
+19.76%
|
-
|
|
Feb 07
2023
|
John Sheldon Peters Chief Insurance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+37.98%
|
-
|
|
Feb 07
2023
|
Adina Eckstein Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+41.67%
|
-
|
|
Feb 02
2023
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.5%
|
$20,000
$2.65 P/Share
|
|
Nov 01
2022
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
4,265
-32.19%
|
$106,625
$25.0 P/Share
|
|
Nov 01
2022
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,265
+24.35%
|
$8,530
$2.65 P/Share
|
|
Oct 19
2022
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,985
+50.0%
|
$17,970
$2.65 P/Share
|
|
Aug 18
2022
|
Mwashuma Kamata Nyatta Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,158
+50.0%
|
-
|
|
Jun 08
2022
|
Silvija Martincevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,285
+40.59%
|
$145,700
$20.59 P/Share
|
|
Jun 08
2022
|
Irina Novoselsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,285
+40.59%
|
$145,700
$20.59 P/Share
|
|
Mar 17
2022
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
7,500
-3.3%
|
$165,000
$22.07 P/Share
|
|
Mar 16
2022
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
5,000
-4.2%
|
$100,000
$20.32 P/Share
|
|
Jan 19
2022
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
10,537
-100.0%
|
$347,721
$33.05 P/Share
|
|
Nov 03
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
500
-4.53%
|
$36,000
$72.0 P/Share
|
|
Nov 03
2021
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+4.33%
|
$1,000
$2.65 P/Share
|
|
Nov 03
2021
|
Timothy E Bixby Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-2.33%
|
$1,110,000
$74.93 P/Share
|
|
Nov 01
2021
|
Timothy E Bixby Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.22%
|
$315,000
$63.9 P/Share
|
|
Oct 18
2021
|
Timothy E Bixby Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.17%
|
$320,000
$64.97 P/Share
|
|
Sep 10
2021
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.95%
|
$770,000
$77.0 P/Share
|
|
Sep 01
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
500
-2.29%
|
$39,000
$78.24 P/Share
|
|
Sep 01
2021
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+4.33%
|
$1,000
$2.65 P/Share
|
|
Aug 02
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
750
-3.37%
|
$66,750
$89.01 P/Share
|
|
Aug 02
2021
|
John Sheldon Peters Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+6.23%
|
$1,500
$2.65 P/Share
|
|
Jul 21
2021
|
Adina Eckstein Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+40.0%
|
-
|
|
Jun 09
2021
|
Irina Novoselsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,427
+29.7%
|
-
|
|
Jun 09
2021
|
Silvija Martincevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,427
+29.7%
|
-
|
|
Jun 08
2021
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
10,000
-2.93%
|
$1,030,000
$103.77 P/Share
|
|
Jun 07
2021
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
10,000
-3.7%
|
$970,000
$97.2 P/Share
|
|
Jun 02
2021
|
Joel E Cutler Director |
SELL
Open market or private sale
|
Indirect |
555,557
-9.47%
|
$53,889,029
$97.15 P/Share
|
|
May 28
2021
|
Michael A Eisenberg Director |
SELL
Open market or private sale
|
Direct |
20,000
-21.95%
|
$1,800,000
$90.27 P/Share
|
|
May 18
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Bona fide gift
|
Direct |
1,000
-8.67%
|
-
|
|
Apr 21
2021
|
Silvija Martincevic Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+50.0%
|
-
|
|
Apr 21
2021
|
Irina Novoselsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+50.0%
|
-
|
|
Apr 15
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
5,500
-32.28%
|
$489,500
$89.84 P/Share
|
|
Mar 16
2021
|
Becker Caryn Seidman Director |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$2,650,000
$106.8 P/Share
|
|
Mar 16
2021
|
Becker Caryn Seidman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$125,000
$5.26 P/Share
|
|
Mar 15
2021
|
John Sheldon Peters Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
5,500
-24.4%
|
$583,000
$106.0 P/Share
|
|
Mar 10
2021
|
Haim Sadger Director |
BUY
Other acquisition or disposition
|
Direct |
77,887
+18.26%
|
-
|
|
Mar 10
2021
|
Haim Sadger Director |
BUY
Other acquisition or disposition
|
Indirect |
8,491
+18.26%
|
-
|